drugset / Trial / NCT00563498

Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients

NCT00563498

RandomizedParallel-groupDouble-blindPrevention

Summary

The primary purpose of this project is to investigate if addition of glutamine, an amino acid, to standard parenteral nutrition, may improve the clinical outcome of the bone marrrow transplantation reducing the occurrence of veno-occlusive disease and severity of mucositis.

Timeline

Start
2004-07
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified